Koya Medical’s Dayspring compression system launched for lower extremity treatment of lymphedema and venous disorders

Koya Medical announced the United States commercial availability of its Dayspring active compression system for the treatment of lymphedema and venous diseases in the lower extremities.
The company also announced that the Centers for Medicare & Medicaid Services (CMS) issued three new billing codes in accordance with the Healthcare Common Procedure Coding System for the Dayspring active compression system. The new CMS codes became effective for provider billing on Apr. 1, 2022.
Dayspring is a non-pneumatic active dynamic compression treatment. In May 2021, the company announced FDA clearance of Dayspring for treatment

of the lower extremities.
The device was cleared for treatment of the upper extremities in 2020 and commercially launched for this indication in 2021.
According to Koya Medical, the wearable Dayspring system is designed to support essential body movement and mobility so patients can continue their daily activities during treatment.
The Dayspring system includes a soft, breathable mesh garment made with the company’s Flexframe technology, which creates spring-like segments that deliver controlled and customizable compression while allowing natural movement. The system also comes with a smart, rechargeable, and Bluetooth-

enabled controller and a companion app that allows users and their clinicians to customize treatments and review treatment history, stated Koya Medical. VTN

Previous post

AngioDynamics Auryon system to be studied in BTK arteries

Next post

Alucent’s natural vascular scaffolding to be evaluated in ACTIVATE II FIH trial

Jason Knight

Jason Knight